175 related articles for article (PubMed ID: 31821886)
41. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
[TBL] [Abstract][Full Text] [Related]
42. Biology and treatment of HTLV-1 associated T-cell lymphomas.
Tsukasaki K; Tobinai K
Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636
[TBL] [Abstract][Full Text] [Related]
43. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.
Kannagi M
Int J Hematol; 2007 Aug; 86(2):113-7. PubMed ID: 17875523
[TBL] [Abstract][Full Text] [Related]
44. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
Ishitsuka K; Tamura K
Lancet Oncol; 2014 Oct; 15(11):e517-26. PubMed ID: 25281470
[TBL] [Abstract][Full Text] [Related]
45. [Impact of pretransplant anti-CCR4 antibody administration on clinical outcomes in allogeneic hematopoietic stem cell transplantation].
Fuji S
Rinsho Ketsueki; 2019; 60(8):968-972. PubMed ID: 31484897
[TBL] [Abstract][Full Text] [Related]
46. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.
Fuji S; Shindo T
Stem Cell Investig; 2016; 3():70. PubMed ID: 27868052
[TBL] [Abstract][Full Text] [Related]
47. Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation.
Tokunaga M; Uto H; Takeuchi S; Nakano N; Kubota A; Tokunaga M; Takatsuka Y; Seto M; Ido A; Utsunomiya A
Leuk Lymphoma; 2017 Jan; 58(1):37-44. PubMed ID: 27654808
[TBL] [Abstract][Full Text] [Related]
48. Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT.
Nakano N; Utsunomiya A; Matsuo K; Yoshida N; Seto M; Ohshima K; Fujiwara H; Fuji S; Takatsuka Y; Ito A; Miyamoto T; Suehiro Y; Nakamae H; Sawayama Y; Yuasa M; Miyazaki Y; Ota S; Imada K; Fukuda T; Ichinohe T; Atsuta Y; Kato K
Blood Adv; 2021 Jan; 5(2):475-486. PubMed ID: 33496743
[TBL] [Abstract][Full Text] [Related]
49. [Adult T cell leukemia/lymphoma (ATL)].
Tanosaki R
Nihon Rinsho; 2003 Sep; 61(9):1592-5. PubMed ID: 14515729
[TBL] [Abstract][Full Text] [Related]
50. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
51. Current status of therapeutic approaches to adult T-cell leukemia.
Ishikawa T
Int J Hematol; 2003 Nov; 78(4):304-11. PubMed ID: 14686487
[TBL] [Abstract][Full Text] [Related]
52. High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.
Shigematsu A; Kobayashi N; Yasui H; Shindo M; Kakinoki Y; Koda K; Iyama S; Kuroda H; Tsutsumi Y; Imamura M; Teshima T
Biol Blood Marrow Transplant; 2014 Jun; 20(6):801-5. PubMed ID: 24565990
[TBL] [Abstract][Full Text] [Related]
53. Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1.
Nagafuji K; Harada M; Teshima T; Eto T; Takamatsu Y; Okamura T; Murakawa M; Akashi K; Niho Y
Blood; 1993 Nov; 82(9):2823-8. PubMed ID: 7693049
[TBL] [Abstract][Full Text] [Related]
54. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan.
Yamaguchi K; Watanabe T
Int J Hematol; 2002 Aug; 76 Suppl 2():240-5. PubMed ID: 12430931
[TBL] [Abstract][Full Text] [Related]
55. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.
Dhakal B; D'Souza A; Martens M; Kapke J; Harrington AM; Pasquini M; Saber W; Drobyski WR; Zhang MJ; Hamadani M; Hari PN
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):379-86. PubMed ID: 27160644
[TBL] [Abstract][Full Text] [Related]
56. Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP.
Bazarbachi A; Cwynarski K; Boumendil A; Finel H; Fields P; Raj K; Nagler A; Mohty M; Sureda A; Dreger P; Hermine O
Bone Marrow Transplant; 2014 Oct; 49(10):1266-8. PubMed ID: 25029232
[TBL] [Abstract][Full Text] [Related]
57. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
Nasr R; Marçais A; Hermine O; Bazarbachi A
Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
[TBL] [Abstract][Full Text] [Related]
58. Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?
Phillips EH; Hodson A; Hermine O; Bazarbachi A; Cwynarski K
Bone Marrow Transplant; 2016 Dec; 51(12):1549-1555. PubMed ID: 27618683
[TBL] [Abstract][Full Text] [Related]
59. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
60. [Tax-targeted dendritic cell vaccine therapy for long-term remission of adult T-cell leukemia-lymphoma].
Suehiro Y
Rinsho Ketsueki; 2023; 64(7):670-677. PubMed ID: 37544729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]